Delivery Order SPE2DE24D0013-SPE2D626F48FL

The Defense Logistics Agency Medical Supply Chain issued a delivery order to Cepheid on February 5, 2026, with a ceiling value of $1,477.60 and an ultimate completion date of February 12, 2026. This is a firm fixed-price delivery order placed against Cepheid's existing supply relationship with DLA Medical Supply Chain. Place of performance is Sunnyvale, CA 94089. The order represents a call for diagnostic supplies or reagents within Cepheid's established federal molecular diagnostics procurement...

<p>The Defense Logistics Agency Medical Supply Chain issued a $10,024.20 delivery order to Cepheid on February 6, 2026, for molecular diagnostic supplies with an ultimate completion date of February 13, 2026.</p> <p>Place of performance is Sunnyvale, CA 94089. The order is firm fixed price with no set-aside. The source does not identify the parent IDV or vehicle name under which this delivery order was issued.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a $2,024.00 delivery order to Cepheid on February 5, 2026, with ultimate completion on February 12, 2026. Place of performance is Sunnyvale, California. The order is firm fixed price with no set-aside.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a $3,194.60 delivery order to Cepheid on February 5, 2026, for diagnostic test kits with an ultimate completion date of February 12, 2026.</p> <p>Place of performance is Sunnyvale, CA 94089. The order is priced on a firm fixed-price basis with no set-aside used.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a $11,040 delivery order to Cepheid on February 6, 2026, for molecular diagnostic supplies with an ultimate completion date of February 13, 2026. Place of performance is Sunnyvale, CA. The order is firm fixed price with no set-aside designation.</p>

The Defense Logistics Agency Medical Supply Chain issued a $6,800 delivery order to Cepheid on February 5, 2026, under a parent Indefinite Delivery Contract for molecular diagnostic reagents and test kits. Place of performance is Sunnyvale, CA 94089. The order has a firm fixed-price structure with an ultimate completion date of February 12, 2026. The delivery covers diagnostic testing supplies supporting Cepheid's GeneXpert diagnostic platform, which provides molecular testing for infectious...

On January 21, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,720 to Cepheid Inc. for diagnostic supplies. This firm fixed-price delivery order, issued under the XPRS4PLEX-10 contract with an ultimate completion date of January 28, 2026, represents a child order under a larger Indefinite Delivery Vehicle. The award carries no set-aside designation and is being performed in Sunnyvale, California, where Cepheid is headquartered. The delivery order...

The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,277.84 to Cepheid Inc. (Sunnyvale, CA) on January 14, 2026, with an ultimate completion date of January 22, 2026. This firm fixed-price delivery order, which carries no set-aside designation, is issued under a larger indefinite delivery contract vehicle and represents a child contract action. Cepheid, a leading manufacturer of molecular diagnostic systems and reagents, provides the GeneXpert diagnostic...

The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,208 on a firm fixed-price basis to Cepheid Inc. on January 5, 2026, with an ultimate completion date of January 12, 2026. The order, designated XPRSTREPA-10, represents a minimal-value procurement typical of supply chain replenishment activities. This delivery order is issued without a set-aside designation and is to be performed at Cepheid's headquarters in Sunnyvale, California. The award falls under the...

The Defense Logistics Agency Medical Supply Chain awarded a $1,757.00 firm fixed-price delivery order to Cepheid Inc. on November 5, 2025, with an ultimate completion date of November 20, 2025. This delivery order, issued without a set-aside designation, supports the agency's molecular diagnostic supply requirements and leverages Cepheid's established expertise as a primary federal supplier of diagnostic solutions. The work will be performed at Cepheid's headquarters in Sunnyvale, California....